Completed PHASE2 INTERVENTIONAL 2-arm NCT01315938

Abatacept Treatment in Polymyositis and Dermatomyositis (ARTEMIS)

Sponsor: Institute of Rheumatology, Prague

Interventions Abatacept Active Treatment Abatacept Delayed-Onset Treatment

Updated 5 times since 2017 Last updated: Nov 3, 2020 Started: Jan 31, 2011 Primary completion: Nov 28, 2013 Completion: Nov 28, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Dermatomyositis and Polymyositis and is currently completed. Institute of Rheumatology, Prague leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Dec 2020 — Jan 2021 [monthly]

Completed PHASE2

Status: Unknown Status → Completed
Jan 2017 — Dec 2020 [monthly]

Unknown Status PHASE2

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institute of Rheumatology, Prague
Karolinska Institutet
King's College Hospital NHS Trust

Data source: Karolinska Institutet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Prague, Czechia
• Stockholm, Sweden